Class of Drugs Gets Stronger Warning on Cancer Risk Tuesday, August 4, 5:21 PM ET
Several multi-billion dollar drugs from Johnson & Johnson (NYSE:JNJ), Abbott Labs (NYSE:ABT), Amgen (NASDAQ:AMGN) and Wyeth (WYE) will soon carry a stronger "black box" warning about potential cancer risk.
The group of drugs, known as tumor necrosis factor blockers, neutralizes inflammation-causing proteins and are used to treat arthritis and other inflammatory diseases.
After a review, the Food and Drug Administration says the drugs increase cancer risk in children and adolescents if taken for more than two and a half years. The drugs are prescribed to children with rheumatoid arthritis, inflammatory bowel disorder, and Crohn's disease.
Affected drugs include Johnson & Johnson's Remicade and Simponi, Abbott Laboratories' Humira, and Amgen and Wyeth's joint product Enbrel.
PAG Crosses Above Key Moving Average Level Friday, April 26, 4:09 PM ET, by Market News Video Staff In trading on Friday, shares of Penske Automotive Group Inc (PAG) crossed above their 200 ...
NEU Crosses Below Key Moving Average Level Friday, April 26, 3:54 PM ET, by Market News Video Staff In trading on Friday, shares of NewMarket Corp (NEU) crossed below their 200 day moving ...
Resources Connection Enters Oversold Territory Friday, April 26, 3:54 PM ET, by Market News Video Staff The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, ...
Federated Hermes Enters Oversold Territory Friday, April 26, 3:52 PM ET, by Market News Video Staff The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, ...
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.